Target intelligence / Profile preview

Desmosome

Molecular classification
Other (Cell adhesion junction; multiprotein complex)
01

Overview

A desmosome is a highly specialized, multi-protein complex forming intercellular junctions critical for strong adhesion between epithelial cells, particularly in tissues subject to mechanical stress such as the skin and heart[1][2][4][6]. Core components include transmembrane cadherins (desmogleins and desmocollins), armadillo family proteins (plakoglobin and plakophilins), and the cytolinker desmoplakin, which connects the junctions to intermediate filaments of the cytoskeleton[1][2][3]. Desmosomes provide mechanical stability, organize cytoskeletal networks, and help maintain structural tissue resilience[1][4][6]. Dysfunction or autoimmune targeting of desmosomal proteins underlies several skin blistering disorders (e.g., pemphigus vulgaris) and some forms of cardiomyopathy[3][5]. As a multi-protein junctional complex rather than a single molecular entity (such as a receptor or enzyme), the desmosome itself is generally not considered a direct therapeutic target, though individual desmosomal proteins—most notably desmogleins—are implicated in disease and can serve as pathological biomarkers[1][3][5]. Clarification: The term “Epidermal cell desmosome complex” is a structural, not a single molecular, target. It refers to the entire desmosomal junction, which comprises several distinct proteins. Its complexity and redundancy limit suitability as a therapeutic molecular target or pharmacological "receptor." The precise names for drug targeting or biomarker use are typically those of its major protein constituents (e.g., desmoglein 1, desmoglein 3, desmoplakin) rather than the complex as a whole[5].

Other names
Macula adherensCell-cell desmosome junctionEpidermal desmosome complex
02

Biological functions

Cell–cell adhesionMaintenance of tissue integrityCytoskeletal couplingTissue morphogenesisEpidermal stratificationCell signaling
03

Disease associations

Skin diseases (e.g., pemphigus vulgaris, Darier disease)CardiomyopathiesEpidermal blistering diseasesOther
04

Safety considerations

Desmosome disruption can lead to loss of tissue cohesion (blistering)cardiac arrhythmiacompromised barrier function, limiting safe targeting
05

Biomarkers

Desmoglein 1Desmoglein 3Desmoplakin (for some skin diseases such as pemphigus)

Beyond the preview

Go deeper on Desmosome.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Desmosome.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call